The FOXO3a transcription factor is a target of cell survival and proliferative signaling by the NPM-ALK fusion kinase of anaplastic large cell lymphoma.

被引：0
|
作者：
Sternberg, DW
Gu, TL
Tothova, Z
Scheijen, B
Griffin, JD
Gilliland, DG
机构：
[1] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
78
引用
收藏
页码：25A / 25A
页数：1
相关论文
共 50 条
  • [1] NPM-ALK fusion kinase of anaplastic large-cell lymphoma regulates survival and proliferative signaling through modulation of FOXO3a
    Gu, TL
    Tothova, Z
    Scheijen, B
    Griffin, JD
    Gilliland, DG
    Sternberg, DW
    BLOOD, 2004, 103 (12) : 4622 - 4629
  • [2] Glycoproteomic signature of NPM-ALK (+) anaplastic large cell lymphoma
    Jeon, Y. K.
    Rolland, D.
    Basrur, V.
    Wolfe, T.
    Fermin, D.
    Elenitoba-Johnson, K. S.
    Lim, M. S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 : 32 - 32
  • [3] Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas
    Drexler, HG
    Gignac, SM
    von Wasielewski, R
    Werner, M
    Dirks, WG
    LEUKEMIA, 2000, 14 (09) : 1533 - 1559
  • [4] NPM-ALK and the JunB transcription factor regulate the expression of cytotoxic molecules in ALK-positive, anaplastic large cell lymphoma
    Pearson, Joel D.
    Lee, Jason K. H.
    Bacani, Julinor T. C.
    Lai, Raymond
    Ingham, Robert J.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2011, 4 (02): : 124 - 133
  • [5] Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas
    HG Drexler
    SM Gignac
    R von Wasielewski
    M Werner
    WG Dirks
    Leukemia, 2000, 14 : 1533 - 1559
  • [6] Ribozyme-mediated cleavage of the NPM-ALK transcript coding for chimeric tyrosine kinase associated with anaplastic large cell lymphoma.
    Hübinger, G
    Wehnis, E
    Maurer, U
    Morris, SW
    Bergmann, L
    BLOOD, 1999, 94 (10) : 598A - 598A
  • [7] MKK4 and MKK7 Interact with NPM-ALK and Contribute to Tumor Cell Proliferation and Survival in NPM-ALK plus Anaplastic Large Cell Lymphoma
    Rassidakis, G.
    Georgoulis, P.
    Atsaves, V.
    Tsioli, P.
    Drakos, E.
    Medeiros, L. J.
    Panayiotidis, P.
    Patsouris, E.
    LABORATORY INVESTIGATION, 2010, 90 : 318A - 318A
  • [8] Analysis of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-reactive CD8+ T cell responses in children with NPM-ALK+ anaplastic large cell lymphoma
    Singh, V. K.
    Werner, S.
    Hackstein, H.
    Lennerz, V.
    Reiter, A.
    Woelfel, T.
    Damm-Welk, C.
    Woessmann, W.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2016, 186 (01): : 96 - 105
  • [9] MKK4 and MKK7 Interact with NPM-ALK and Contribute to Tumor Cell Proliferation and Survival in NPM-ALK plus Anaplastic Large Cell Lymphoma
    Rassidakis, G.
    Georgoulis, P.
    Atsaves, V.
    Tsioli, P.
    Drakos, E.
    Medeiros, L. J.
    Panayiotidis, P.
    Patsouris, E.
    MODERN PATHOLOGY, 2010, 23 : 318A - 318A
  • [10] Prognostic significance of NPM-ALK fusion transcript overexpression in ALK-positive anaplastic large-cell lymphoma
    Li, Chunmei
    Takino, Hisashi
    Eimoto, Tadaaki
    Ishida, Takashi
    Inagaki, Atsushi
    Ueda, Ryuzo
    Suzuki, Ritsuro
    Yoshino, Tadashi
    Nakagawa, Atsuko
    Nakamura, Shigeo
    Inagaki, Hiroshi
    MODERN PATHOLOGY, 2007, 20 (06) : 648 - 655
12345